BLUE BIOFUELS, INC.
For the period ended Jun 30, 2025. Filed Jul 31, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Jul 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities
Below is a list of securities issued by the Company from January 1, 2025, through the date of filing which were not registered under the Securities Act.
| Entity | Date of Investment | Title of Security | Amount of Securities Sold | Consideration |
|---|---|---|---|---|
| Clay Taylor | 01/21/25 | Common Stock | 625,000 | Note Conversion |
| Peter Zimeri | 02/18/25 | Common Stock | 44,000 | Exercise of Options |
| Anthony Santelli, Sr. | 04/04/25 | Common Stock | 500,000 | Purchase @ $0.10 per share |
| Anthony Santelli, Sr. | 05/05/25 | Common Stock | 250,000 | Purchase @ $0.10 per share |
| Thomas Camerlengo | 05/08/25 | Common Stock | 106,687 | Exercise of Options |
| Randall Brodsky | 05/21/25 | Common Stock | 250,000 | Purchase @ $0.10 per share |
| Anthony Santelli, Sr. | 05/24/25 | Common Stock | 500,000 | Purchase @ $0.10 per share |
| Mark Monahan | 05/30/25 | Common Stock | 500,000 | Purchase @ $0.10 per share |
| John Orlando | 06/09/25 | Common Stock | 125,000 | Exercise of Warrants |
| Anthony Santelli, Sr. | 06/26/25 | Common Stock | 600,000 | Purchase @ $0.10 per share |
| David Bolton | 07/02/25 | Common Stock | 250,000 | Purchase @ $0.10 per share |
| Peter van Eerten | 07/09/25 | Common Stock | 400,000 | Purchase @ $0.10 per share |
The securities issued in the above-mentioned transactions were issued in connection with private placements exempt from the registration requirements of Section 5 of the Securities Act of 1933, as amended, pursuant to the terms of Section 4(a)(2) of that Act and Rules 504 and 506 of Regulation D.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.